Neonatal Stand-Alone Screening Kit For Metabolic Disorders Cleared By FDA
This article was originally published in The Gray Sheet
Executive Summary
PerkinElmer will market its NeoGram amino acids and acylcarnitines tandem mass spectrometry (TMS) kit as a cost-effective alternative to laboratory blood testing for individual defects of metabolism among newborns